Citation Impact
Citing Papers
Anthelmintic Avermectins Kill Mycobacterium tuberculosis, Including Multidrug-Resistant Clinical Strains
2012
Discovery, mechanisms of action and combination therapy of artemisinin
2009 Standout
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis
2004
Treatment strategies underpinning the global programme to eliminate lymphatic filariasis
2005
The onchocerciasis chronicle: from the beginning to the end?
2012 StandoutNobel
Ferroptosis: past, present and future
2020 Standout
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018 Standout
Pharmacokinetic and Toxicological Profile of Artemisinin Compounds: An Update
2009
Leishmaniasis
2018 Standout
Trial of oral miltefosine for visceral leishmaniasis
1998
Embryotoxicity of the artemisinin antimalarials and potential consequences for use in women in the first trimester
2009
Drug resistance in Indian visceral leishmaniasis
2001
Ferroptosis: Death by Lipid Peroxidation
2015 Standout
Entrapment and release of quinoline derivatives using a hydrogel of a low molecular weight gelator
2004 StandoutNobel
Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs
2005
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
2007 Standout
Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate.
2001
A policy for leishmaniasis with respect to the prevention and control of drug resistance
2001
Mechanism and medical implications of mammalian autophagy
2018 Standout
Molecular Understanding and Modern Application of Traditional Medicines: Triumphs and Trials
2007 Standout
Natural products: A continuing source of novel drug leads
2013 Standout
Mechanical Strain and Bone Cell Function: A Review
2002
Hepatitis C virus infection in mouse hepatoma cells co-expressing human CD81 and Sip-L
2008
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Pharmacokinetics of artesunate after single oral administration to rats
2001
CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
2002 StandoutNature
Innovative lead discovery strategies for tropical diseases
2006
Soil-transmitted helminth infections
2017
From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy
2017
Production of the antimalarial drug precursor artemisinic acid in engineered yeast
2006 StandoutNature
Lymphatic filariasis and onchocerciasis
2010 Standout
Human African trypanosomiasis
2009
COVID-19: A promising cure for the global panic
2020 Standout
Cutaneous leishmaniasis
2007 Standout
Ivermectin: uses and impact 20 years on
2006
Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis
2008
Antimony determination in tissues and serum of hamsters infected withLeishmania garnhamiand treated with meglumine antimoniate
1994
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
Combination therapy for visceral leishmaniasis
2010
Chemotherapy in the Treatment and Control of Leishmaniasis
2006
Malaria
2013 Standout
Chemotherapy for Leishmaniasis: Biochemical Mechanisms, Clinical Efficacy, and Future Strategies
1988
Artemisinin derivatives: toxic for laboratory animals, safe for humans?
2004
Practical Guide for the Treatment of Leishmaniasis
1998
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
2015
Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells
2015
Mass drug treatment for lymphatic filariasis and onchocerciasis
2003
Broadening horizons: the role of ferroptosis in cancer
2021 Standout
Mefloquine resistance in Plasmodium falciparum
1995
Disseminated Strongyloides stercoralis: Hyperinfection during medical immunosuppression
2010
Development of artemisinin and its structurally simplified trioxane derivatives as antimalarial drugs
2004
Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets
2018
Identification of an antimalarial synthetic trioxolane drug development candidate
2004 Nature
A Brief History of the Antibiotic Era: Lessons Learned and Challenges for the Future
2010 Standout
Ivermectin: panacea for resource-poor communities?
2014 StandoutNobel
Ferroptosis: process and function
2016 Standout
Worms at Work: Long-run Impacts of a Child Health Investment*
2016 StandoutNobel
Efficacy of moxidectin microsphere sustained release formulation for the prevention of subcutaneous filarial (Dirofilaria repens) infection in dogs
2010
Pharmacokinetics of amifostine and its metabolites in patients
1997
Albendazole for the control and elimination of lymphatic filariasis: systematic review
2005
River Blindness: A Success Story under Threat?
2006
Helminth infections: the great neglected tropical diseases
2008 Standout
Doxorubicin-Induced Cardiomyopathy
1998 Standout
The past, present and future of anti-malarial medicines
2019
Control of Neglected Tropical Diseases
2007 Standout
Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi.
2001
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda
2002
Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria
1992
Arsenic and antimony: comparative approach on mechanistic toxicology
1997
The effect of oral anthelmintics on the survivorship and re-feeding frequency of anthropophilic mosquito disease vectors
2010
WR2721 as a modulator of cisplatin-and carboplatin-induced side effects in comparison with other chemoprotective agents: a molecular approach
1993
Leishmaniasis
1999 Standout
A PHASE II DOSE-RANGING STUDY OF SITAMAQUINE FOR THE TREATMENT OF VISCERAL LEISHMANIASIS IN INDIA
2005
Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
1994
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Solution-phase total synthesis of the hydrophilic natural product argifin using 3,4,5-tris(octadecyloxy)benzyl tag
2011 StandoutNobel
Leishmania and human immunodeficiency virus coinfection: the first 10 years
1997
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
2020 Standout
The Hitchhiker’s Guide to Flow Chemistry
2017 Standout
Albendazole for lymphatic filariasis
2005
Photoinitiated Polymerization: Advances, Challenges, and Opportunities
2010 Standout
Human and Animal Dirofilariasis: the Emergence of a Zoonotic Mosaic
2012 Standout
Preparative Microfluidic Electrosynthesis of Drug Metabolites
2013
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
In Vitro and In Vivo Treatments of Echinococcus Protoscoleces and Metacestodes with Artemisinin and Artemisinin Derivatives
2008
Echinococcosis: Advances in the 21st Century
2019 Standout
Clinical and Experimental Advances in Treatment of Visceral Leishmaniasis
2001
Interventions for Old World cutaneous leishmaniasis
2008
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Intralesional therapy of American cutaneous leishmaniasis with pentavalent antimony in Rio de Janeiro, Brazil – an area of Leishmania (V.) braziliensis transmission
1997
Observation of the controlled assembly of preclick components in the in situ click chemistry generation of a chitinase inhibitor
2013 StandoutNobel
Advances in leishmaniasis
2005 Standout
Metal emissions from road traffic and the influence of resuspension—results from two tunnel studies
2002 Standout
Stereochemical evaluation of the relative activities of the cinchona alkaloids against Plasmodium falciparum
1992
Human Leishmaniasis: Clinical, Diagnostic, and Chemotherapeutic Developments in the Last 10 Years
1997
Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy
1996 Standout
Effects of written drug information on patient knowledge and compliance: a literature review.
1979 Standout
Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System Infections
2010 Standout
The Cinchona Primary Amine-Catalyzed Asymmetric Epoxidation and Hydroperoxidation of α,β-Unsaturated Carbonyl Compounds with Hydrogen Peroxide
2013 StandoutNobel
Creation of Customized Bioactivity within a 14-Membered Macrolide Scaffold: Design, Synthesis, and Biological Evaluation Using a Family-18 Chitinase
2015 StandoutNobel
Nature’s hierarchical materials
2007 Standout
An axenic amastigote system for drug screening
1997
Antileishmanial activity of sodium stibogluconate fractions
1993
Prophylaxis of Plasmodium falciparum Infection in a Human Challenge Model with WR 238605, a New 8-Aminoquinoline Antimalarial
1998
Pharmacokinetics of Antimony in Patients Treated with Sodium Stibogluconate for Cutaneous Leishmaniasis
1995
Diagnosis and treatment of Indian visceral leishmaniasis.
2003
Towards a small animal model for hepatitis C
2009 StandoutNobel
Repositioning of an existing drug for the neglected tropical disease Onchocerciasis
2010
Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells
2015
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Macrofilaricidal Activity and Amelioration of Lymphatic Pathology in Bancroftian Filariasis after 3 Weeks of Doxycycline Followed by Single-Dose Diethylcarbamazine
2009
Artemisinins
2005
Drug Resistance in Leishmaniasis
2006 Standout
Generation of Anti-trypanosomal Agents through Concise Synthesis and Structural Diversification of Sesquiterpene Analogues
2011 StandoutNobel
Works of Lawrence Fleckenstein being referenced
The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole
2002
Review of pyronaridine anti-malarial properties and product characteristics
2012
Disposition of the radioprotector ethiofos in the rhesus monkey. Influence of route of administration.
1989
Pharmacokinetics of oral moxidectin in individuals with Onchocerca volvulus infection
2022
Clinical pharmacokinetics of suramin in patients with onchocerciasis
1998
Simultaneous Modeling of the Pharmacokinetics and Methemoglobin Pharmacodynamics of an 8-Aminoquinoline Candidate Antimalarial (WR 238605)
1991
HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies
2002
Mefloquine kinetics in cured and recrudescent patients with acute falciparum malaria and in healthy volunteers
1990
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial
2010
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration
2011
Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India
2004
Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs
2002
The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in Humans
2003
Fixed‐Dose Pyronaridine‐Artesunate Combination for Treatment of Uncomplicated Falciparum Malaria in Pediatric Patients in Gabon
2008
Treatment of Human Disseminated Strongyloidiasis with a Parenteral Veterinary Formulation of Ivermectin
2005
Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria
2012
Bioavailability and newer methods of delivery of phosphorothioate radioprotectors
1988
Transdermal Artelinic Acid: an Effective Treatment for Plasmodium Berghei-Infected Mice
1991
Phase 2 Efficacy Trial of an Oral 8-Aminoquinoline (WR6026) for Treatment of Visceral Leishmaniasis
1994
Pharmacokinetics of chloroquine diphosphate in the dog.
1983
Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate
1988
The Disposition of Quinine in the Rat Isolated Perfused Liver: Effect of Dose Size
1990
Oral Contraceptive Patient Information
1976
PARENTERAL ADMINISTRATION OF IVERMECTIN IN A PATIENT WITH DISSEMINATED STRONGYLOIDIASIS
2005
The Pharmacokinetics and Bioavailability of Dihydroartemisinin, meether, Artemether, Artesunic Acid and Artelinic Acid in Rats
1998
Oral contraceptive patient information. A questionnaire study of attitudes, knowledge, and preferred information sources
1976
Safety and efficacy field study of artesunate for dogs with non-resectable tumours.
2013
Pharmacokinetics and disposition of WR-1065 in the rhesus monkey.
1990